Liminatus Pharma, Inc. LIMN
2.77 USD +0.09 (+3.20%)
Nov 10, 2026, 3:42 PM EST
2.77 Day range 2.91
2.40 52-week range 141.50
- YTD
- -90.92%
- 1 year
- -95.34%
- Market cap
- 3.72M
- EPS (ttm)
- -23.50
- YTD return
- -90.92%
- 1-year return
- -95.34%
- Volume
- 18.52K
- Avg volume
- 213.21K
- Open
- 2.80
- Previous close
- 2.69
- Day's range
- 2.77 – 2.91
- 52-week range
- 2.40 – 141.50
5D -0.35 (-12.11%)
Financials — quick view
LIMN Revenue — quarterly 0
LIMN Net income — quarterly -1.41M
LIMN EPS — quarterly -1.50
News
12 Health Care Stocks Moving In Friday's Pre-Market Session 
Liminatus Pharma Regains Compliance With Nasdaq’s Minimum Bid Price Rule - 12 Health Care Stocks Moving In Wednesday's After-Market Session
Liminatus Pharma Engages Synex Consulting To Support Clinical Development Of IBC101, CD19xCD22 Bivalent CAR-T Cell Therapy Candidate - 12 Health Care Stocks Moving In Tuesday's After-Market Session
Liminatus Pharma Board Adopts Resolutions Approving Reverse Stock Split Of Its Common Stock At Ratio Of 1-For-50 - 12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
12 Health Care Stocks Moving In Friday's Intraday Session 
12 Health Care Stocks Moving In Friday's Pre-Market Session
Your note
Sign in to keep a note on LIMN — it syncs with the Stock Master app.